中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 5
May  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(5): 1137-1141

Association between monocyte-to-high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease

DOI: 10.3969/j.issn.1001-5256.2021.05.031

  • Second Department of Gastroenterology, Zhongshan Hospital Affiliated to Dalian University, Dalian, Liaoning 116001, China

  • Received Date: 2020-07-30
  • Accepted Date: 2020-08-31
  • Published Date: 2021-05-20
    Abstract
  •   Objective  To investigate the association between monocyte-to-high-density lipoprotein cholesterol ratio (MHR) and nonalcoholic fatty liver disease (NAFLD).  Methods  A total of 208 patients who were admitted to Department of Gastroenterology, Zhongshan Hospital Affiliated to Dalian University, from January 2018 to October 2020 and were diagnosed with NAFLD by abdominal CT were enrolled as NAFLD group, and 210 healthy individuals were enrolled as control group. All subjects underwent routine blood test, biochemical examination, and abdominal CT examination, and serum MHR was calculated. In addition, according to abdominal CT findings, the patients with NAFLD were divided into mild NAFLD group with 148 patients and moderate-to-severe NAFLD group with 60 patients, and the variables such as white blood cell count (WBC) and MHR were compared between the three groups. The independent samples t-test was used for comparison of normally distributed continuous data between two groups, and a one-way analysis of variance was used for comparison between multiple groups; the Mann-Whitney U test was used for comparison of data with skewed distribution between two groups, and the Kruskal-Wallis H test was used for comparison between multiple groups. The fourfold table chi-square test was used for comparison of categorical data between two groups, and the R×C table chi-square test was used for comparison between three groups. A Spearman correlation analysis was used to investigate the correlation of MHR with metabolic markers and the severity of NAFLD. The receiver operating characteristic (ROC) curve was used to evaluate the diagnostic value of MHR in predicting NAFLD.  Results  Compared with the control group, the NAFLD group had significant increases in body weight (t=-10.573, P < 0.001), body mass index (BMI) (t=-13.112, P < 0.001), smoking history (Z=14.667, P < 0.001), WBC (t=-7.359, P < 0.001), monocytes (Z=-9.932, P < 0.001), low-density lipoprotein cholesterol (t=-3.394, P=0.001), triglyceride (TG) (Z=-11.737, P < 0.001), cholesterol (t=-2.985, P=0.003), fasting blood glucose (FBG) (Z=-7.827, P < 0.001), alanine aminotransferase (ALT) (Z=-12.583, P < 0.001), and aspartate aminotransferase (AST) (Z=-9.514, P < 0.001) and a significant reduction in serum high-density lipoprotein cholesterol (HDL-C) (t=10.440, P < 0.001); in addition, MHR level had gender differences, and male patients had a significantly higher level than female patients (P < 0.001). Compared with the control group and the mild NAFLD group, the moderate-to-severe NAFLD group had a significant increase in serum MHR level (P < 0.001). The correlation analysis showed that serum MHR level was negatively correlated with HDL-C (r=-0.565, P < 0.001) and were positively correlated with smoking history, body weight, BMI, WBC, monocytes, TG, FBG, ALT, and AST (r=0.449, 0.482, 0.430, 0.478, 0.892, 0.333, 0.157, 0.386, and 0.281, all P < 0.01). At the same time, MHR level was positively correlated with the severity of NAFLD (r=0.629, P < 0.001). The ROC curve showed that MHR had an area under the ROC curve of 0.846 (95% confidence interval: 0.810-0.882, P < 0.001), with a sensitivity of 77.9% and a specificity of 74.3%.  Conclusion  Serum MHR level is associated with NAFLD and can be used as a predictive index for evaluating the progression of NAFLD.

     

    • FullText(HTML)
  • loading
    • References(19)
  • [1]
    ESLAM M, SANYAL AJ, GEORGE J, et al. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease[J]. Gastroenterology, 2020, 158(7): 1999-2014. e1. DOI: 10.1053/j.gastro.2019.11.312.
    [2]
    YILMAZ M, KAYANÇIÇEK H. A new inflammatory marker: Elevated monocyte to HDL cholesterol ratio associated with smoking[J]. J Clin Med, 2018, 7(4): 76. DOI: 10.3390/jcm7040076.
    [3]
    KARATAS A, TURKMEN E, ERDEM E, et al. Monocyte to high-density lipoprotein cholesterol ratio in patients with diabetes mellitus and diabetic nephropathy[J]. Biomark Med, 2018, 12(9): 953-959. DOI: 10.2217/bmm-2018-0048.
    [4]
    KAPLAN IG, KAPLAN M, ABACIOGLU OO, et al. Monocyte/HDL ratio predicts hypertensive complications[J]. Bratisl Lek Listy, 2020, 121(2): 133-136. DOI: 10.4149/BLL_2020_018.
    [5]
    USTA A, AVCI E, BULBUL CB, et al. The monocyte counts to hdlcholesterol ratio in obese and lean patients with polycystic ovary syndrome[J]. Reprod Biol Endocrinol, 2018, 16 (1): 34. DOI: 10.1186/s12958-018-0351-0.
    [6]
    VAHIT D, AKBOGA MK, SAMET Y, et al. Assessment of monocyte to high density lipoprotein cholesterol ratio and lymphocyte-to-monocyte ratio in patients with metabolic syndrome[J]. Biomark Med, 2017, 11(7): 535-540. DOI: 10.2217/bmm-2016-0380.
    [7]
    Chinese Medical Association Liver Diseases Branch Fatty Liver and Alcoholic Liver Disease Group, Guidelines for the prevention and treatment of nonalcoholic fatty liver disease (updated version 2018) [J]. J Clin Hepatol, 2018, 34(5): 947-957. DOI: 10.3969/j.issn.1001-5256.2018.05.007.

    中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病防治指南(2018年更新版)[J]. 临床肝胆病杂志, 2018, 34(5): 947-957. DOI: 10.3969/j.issn.1001-5256.2018.05.007.
    [8]
    ALSWAT KA, FALLATAH HI, AL-JUDAIBI B, et al. Position statement on the diagnosis and management of non-alcoholic fatty liver disease[J]. Saudi Med J, 2019, 40(6): 531-540. DOI: 10.15537/smj.2019.6.23980.
    [9]
    MALIAKKAL BJ. Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation[J]. Transl Gastroenterol Hepatol, 2020, 5: 36. DOI: 10.21037/tgh.2019.12.02.
    [10]
    SHAO M, YE Z, QIN Y, et al. Abnormal metabolic processes involved in the pathogenesis of non-alcoholic fatty liver disease (Review)[J]. Exp Ther Med, 2020, 20(5): 26. DOI: 10.3892/etm.2020.9154.
    [11]
    WANG S, ZHANG C, ZHANG G, et al. Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: A prospective cohort study[J]. BMJ Open, 2016, 6(6): e010342. DOI: 10.1136/bmjopen-2015-010342.
    [12]
    ZHANG J, CHEN W, FANG L, et al. Increased intermediate monocyte fraction in peripheral blood is associated with nonalcoholic fatty liver disease[J]. Wien Klin Wochenschr, 2018, 130(11-12): 390-397. DOI: 10.1007/s00508-018-1348-6.
    [13]
    WANG HY, SHI WR, YI X, et al. Assessing the performance of monocyte to high-density lipoprotein ratio for predicting ischemic stroke: Insights from a population-based Chinese cohort[J]. Lipids Health Dis, 2019, 18(1): 127. DOI: 10.1186/s12944-019-1076-6.
    [14]
    LI N, REN L, WANG JH, et al. Relationship between monocyte to HDL cholesterol ratio and concomitant cardiovascular disease in Chinese Han patients with obstructive sleep apnea[J]. Cardiovasc Diagn Ther, 2019, 9(4): 362-370. DOI: 10.21037/cdt.2019.08.02.
    [15]
    JIALAL I, JIALAL G, ADAMS-HUET B, et al. Neutrophil and monocyte ratios to high-density lipoprotein-cholesterol and adiponectin as biomarkers of nascent metabolic syndrome[J]. Horm Mol Biol Clin Investig, 2020, 41(2). DOI: 10.1515/hmbci-2019-0070.
    [16]
    ANCUTA P, WANG J, GABUZDA D. CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells[J]. J Leukoc Biol, 2006, 80(5): 1156-1164. DOI: 10.1189/jlb.0206125.
    [17]
    CHA JY, KIM DH, CHUN KH. The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[J]. Lab Anim Res, 2018, 34(4): 133-139. DOI: 10.5625/lar.2018.34.4.133.
    [18]
    MCMAHAN RH, WANG XX, CHENG LL, et al. Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease[J]. J Biol Chem, 2013, 288(17): 11761-11770. DOI: 10.1074/jbc.M112.446575.
    [19]
    GLASS CK, OLEFSKY JM. Inflammation and lipid signaling in the etiology of insulin resistance[J]. Cell Metab, 2012, 15(5): 635-645. DOI: 10.1016/j.cmet.2012.04.001.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(5)  / Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (580) PDF downloads(46) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return